Position in ABSI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$294,502,456
+$226,849,465 QoQ
Shares Held
25,410,048
+12.7% QoQ
Ownership
14.8%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ABSI ranks #52 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $294,502,456 | 25,410,048 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $67,652,991 | 22,550,997 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $78,113,186 | 22,382,002 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $67,133,707 | 22,083,457 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $49,174,001 | 19,133,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $46,150,989 | 18,386,849 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $35,403,914 | 13,512,945 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $48,620,041 | 12,727,760 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $38,748,259 | 12,580,604 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $84,123,377 | 14,810,454 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $58,218,387 | 13,861,521 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $18,297,207 | 13,861,521 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,069,511 | 13,861,521 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $24,253,619 | 13,859,211 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $29,104,342 | 13,859,211 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $43,589,978 | 13,926,511 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $46,240,036 | 13,927,722 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $117,232,004 | 13,906,525 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $86,627,726 | 10,564,357 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $110,466,193 | 9,498,383 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||